Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 50 of 2070 for:    Pancreatic Cancer AND Digestive System Neoplasms

Institut Paoli-Calmettes Pancreatic Neoplasms Database

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02869581
Recruitment Status : Recruiting
First Posted : August 17, 2016
Last Update Posted : August 17, 2016
Sponsor:
Information provided by (Responsible Party):
Institut Paoli-Calmettes

Brief Summary:
Database of Institut Paoli Calmettes diagnosed with Pancreatic neoplasms

Condition or disease Intervention/treatment
Pancreatic Neoplasms Other: Data collection

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 8500 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 10 Years
Official Title: Institut Paoli-Calmettes Pancreatic Neoplasms Database
Study Start Date : January 2000
Estimated Primary Completion Date : January 2030
Estimated Study Completion Date : December 2030

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Patients with diagnosis of Pancreatic neoplasms Other: Data collection



Primary Outcome Measures :
  1. Survival of patients with pancreatic neoplasms [ Time Frame: 10 years ]
    Overall survival of all patients who come in the center


Secondary Outcome Measures :
  1. Collection of patients characteristics [ Time Frame: 10 years ]
    Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient with a diagnosis of Pancreatic neoplasms
Criteria

Inclusion Criteria:

  • Patient with a diagnosis of Pancreatic neoplasm

Exclusion Criteria:

  • Patient with a diagnosis of cholangiocarcinoma

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02869581


Contacts
Layout table for location contacts
Contact: Dominique Genre, MD 0033491223778 drci.up@ipc.unicancer.fr
Contact: Lilian Laborde 0033491223778 labordel@ipc.unicancer.fr

Locations
Layout table for location information
France
Institut Paoli Calmettes Recruiting
Marseille, Bouches du Rhone, France, 13009
Contact: Dominique GENRE, MD    33 4 91 22 37 78    drci.up@ipc.unicancer.fr   
Sponsors and Collaborators
Institut Paoli-Calmettes

Additional Information:

Layout table for additonal information
Responsible Party: Institut Paoli-Calmettes
ClinicalTrials.gov Identifier: NCT02869581     History of Changes
Other Study ID Numbers: BDD-PANCREAS-IPC
First Posted: August 17, 2016    Key Record Dates
Last Update Posted: August 17, 2016
Last Verified: August 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pancreatic Neoplasms
Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases